Showing results (1761-1770 of 2,739) with videos related to

Sort By:
Pageof 274
Pharmacogenomics|December 20, 2019
Impact of CYP2C9, VKORC1, ApoE and ABCB1 polymorphisms on stable warfarin dose requirements in elderly Chinese patientsWenyan Li, Ping Zhao, Liwen Chen, et al.
Pharmacogenomics|May 9, 2022
Coriell Life Sciences: empowering the most precise medical care for a healthier worldJeffrey A Shaman, Paul H Chernin, Scott E Megill
Pharmacogenomics|February 6, 2018
The pharmacoepigenomics informatics pipeline defines a pathway of novel and known warfarin pharmacogenomics variantsAri Allyn-Feuer, Alex Ade, Jasmine A Luzum, et al.
Pharmacogenomics|December 7, 2018
Prolonged clonazepam-induced withdrawal symptoms in an NAT2 ultraslow acetylatorTeresa T Ho, Sheeba Varghese Gupta, Amarilis Sanchez-Valle
Pharmacogenomics|June 7, 2022
Pharmacogenomics: a tool to improve medication safety and efficacy in patients with cystic fibrosisColleen M Sakon, Emma M Tillman
Pharmacogenomics|June 7, 2022
The Festival of Genetics and Personalized MedicineMaria Therianou, Alexandra Gerou, Konstantinos Mitropoulos, et al.
Pharmacogenomics|May 24, 2022
Pharmacogenetic variants influence vitamin K anticoagulant dosing in patients with mechanical prosthetic heart valvesLinda Koshy, Raghu Vb, Madhuma M, et al.
Pharmacogenomics|June 8, 2021
Novel associations between CYP2B6 polymorphisms, perioperative methadone metabolism and clinical outcomes in childrenSenthil Packiasabapathy, Blessed W Aruldhas, Pengyue Zhang, et al.
Pharmacogenomics|November 18, 2020
Effect of CYP2D6 genetic polymorphism on peak propafenone concentration: no significant effect of CYP2D6*10Kosuke Doki, Yuki Shirayama, Yukio Sekiguchi, et al.
Pharmacogenomics|June 1, 2021
A meta-analysis of effects of CYP2C9 and CYP2C19 polymorphisms on phenytoin pharmacokinetic parametersJuntip Kanjanasilp, Ratree Sawangjit, Sirikhwan Phanthaisong, et al.
Pageof 274